Joseph Benjamin Rucker
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2014First federal award
$6.1MFederal grants as PI14 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
14 awards · $6.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 9, 2024 | NIH | SBIR Phase II Development of Claudin MAbs for Treating Solid Tumors | $395K | INTEGRAL MOLECULAR INC |
| Jun 7, 2023 | NIH | SBIR Phase II Development of Claudin MAbs for Treating Solid Tumors | $709K | INTEGRAL MOLECULAR INC |
| May 31, 2022 | NIH | SBIR Phase II Development of Claudin MAbs for Treating Solid Tumors | $600K | INTEGRAL MOLECULAR INC |
| Mar 17, 2022 | NIH | SBIR Phase II Development of Kv1.3 Monoclonal Antibodies Targeting TEM Cells for Treating Autoimmune Disorders | $589K | INTEGRAL MOLECULAR INC |
| Sep 17, 2021 | NIH | SBIR Phase I Development of Nav1.7 Monoclonal Antibodies for Treating Pain | $475K | INTEGRAL MOLECULAR INC |
| Mar 17, 2021 | NIH | SBIR Phase II Development of Kv1.3 Monoclonal Antibodies Targeting TEM Cells for Treating Autoimmune Disorders | $634K | INTEGRAL MOLECULAR INC |
| Mar 19, 2020 | NIH | SBIR Phase II Development of Kv1.3 Monoclonal Antibodies Targeting TEM Cells for Treating Autoimmune Disorders | $586K | INTEGRAL MOLECULAR INC |
| Jul 26, 2019 | NIH | SBIR Phase I Identifying Agonist MAbs against GPCRs | $132K | INTEGRAL MOLECULAR INC |
| Aug 6, 2018 | NIH | SBIR Phase I Identifying Agonist MAbs against GPCRs | $223K | INTEGRAL MOLECULAR INC |
| Sep 1, 2016 | NIH | SBIR Phase II Development of P2X3 Ion Channel MAbs for the Treatment of Pain | $215K | INTEGRAL MOLECULAR INC |
| Jan 22, 2016 | NIH | SBIR Phase II Engineering of membrane protein chemosensors for therapeutic research | $212K | INTEGRAL MOLECULAR INC |
| Aug 26, 2015 | NIH | SBIR Phase I Development of High-expressing Ion Channels for Research and Therapeutic Applicat | $208K | INTEGRAL MOLECULAR INC |
| Aug 21, 2015 | NIH | SBIR Phase II Development of P2X3 Ion Channel MAbs for the Treatment of Pain | $652K | INTEGRAL MOLECULAR INC |
| Nov 21, 2014 | NIH | SBIR Phase II Engineering of membrane protein chemosensors for therapeutic research | $492K | INTEGRAL MOLECULAR INC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#178
Awards as PI#57
Patents#273
Companies
- INTEGRAL MOLECULAR INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.